Press "esc" to clear
Go to Advanced Search

Showing results

110 of 798

Article ID: 706713

Three tips for sticking with your New Year’s resolutions

Houston Methodist

By February, nearly 80 percent of Americans will give up on their New Year’s resolutions, but a Houston Methodist lifestyle coach says making a few simple changes can help people reach their goals.

Released:
17-Jan-2019 4:05 PM EST
Fractylphoto2.png

Article ID: 706661

Novel same-day Type 2 diabetes treatment study launches in US

University of Texas Health Science Center at Houston

A same-day procedural therapy to improve glucose control for Type 2 diabetes patients will be investigated in a pilot study at The University of Texas Health Science Center at Houston (UTHealth). Absalon D. Gutierrez, MD, and Nirav C. Thosani, MD, are among the first physician-researchers in the country to assess the safety and effectiveness of The Revita™ System, designed to help improve blood sugar levels without the need for additional medications.

Released:
17-Jan-2019 12:05 PM EST
  • Embargo expired:
    15-Jan-2019 10:00 AM EST

Article ID: 706482

MD Anderson Cancer Center and Dragonfly Therapeutics announce strategic collaboration to take new immunotherapy candidates into clinical trials

University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center and Dragonfly Therapeutics, Inc., today announced a strategic collaboration to bring Dragonfly’s TriNKET™ (tri-specific natural killer cell engager therapy) immunotherapy drug candidates to patients in clinical trials beginning in 2019.

Released:
15-Jan-2019 9:05 AM EST
SaferoutestoschoolGettyImages.jpg

Article ID: 706464

UTHealth drives forward programs to stop childhood obesity

University of Texas Health Science Center at Houston

Two grants totaling nearly $3.7 million will support the efforts of The University of Texas Health Science Center at Houston (UTHealth) to combat obesity and help Texas children achieve healthy lifestyles through the mission of the Michael & Susan Dell Center for Healthy Living.

Released:
14-Jan-2019 3:05 PM EST
136398_Shih_T.jpg
  • Embargo expired:
    14-Jan-2019 11:00 AM EST

Article ID: 706200

Complication rates and costs of invasive lung cancer diagnostic tests may be higher than anticipated

University of Texas M. D. Anderson Cancer Center

Complication rates following invasive diagnostic procedures for lung abnormalities were twice as high in community settings compared to those reporter in lung screening trials, according to an MD Anderson study.

Released:
10-Jan-2019 12:05 PM EST
  • Embargo expired:
    11-Jan-2019 10:00 AM EST

Article ID: 706337

VISTA checkpoint implicated in pancreatic cancer immunotherapy resistance

University of Texas M. D. Anderson Cancer Center

MD Anderson researchers have identified a new potential immunotherapy target in pancreatic cancer, which so far has been notoriously resistant to treatment with immune checkpoint blockade drugs effective against a variety of other cancers.

Released:
11-Jan-2019 8:00 AM EST
169226_Pickering_C.jpg
  • Embargo expired:
    10-Jan-2019 9:00 AM EST

Article ID: 706178

Novel Biomarker Appears Predictive of Outcome in Patients with HPV-Related Head and Neck Cancers

University of Texas M. D. Anderson Cancer Center

Rather than classifying based solely on HPV status, MD Anderson researchers have discovered a new biomarker for head and neck cancers that may enable clinicians to better predict patient outcomes and lower treatment intensity to reduce side effects.

Released:
8-Jan-2019 5:05 PM EST
DrMendelsohn_master.jpg

Article ID: 706120

John Mendelsohn, MD Anderson President Emeritus, Passes Away

University of Texas M. D. Anderson Cancer Center

John Mendelsohn, M.D., president emeritus of The University of Texas MD Anderson Cancer Center and an internationally acclaimed leader in the field of medicine and scientist whose research helped pioneer a new type of cancer therapy, died Jan. 7 at his home in Houston. He was 82. The cause of death was glioblastoma, an aggressive form of brain cancer with which he was diagnosed 15 months ago.

Released:
8-Jan-2019 9:40 AM EST

Article ID: 706097

MD Anderson Cancer Center and Nanobiotix announce a large-scale, comprehensive clinical collaboration on NBTXR3

University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center and Nanobiotix today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers, with the first trials to be launched in 2019.

Released:
7-Jan-2019 3:05 PM EST

Showing results

110 of 798

Chat now!